Senior-led quality services delivered as strategic advisory, project leadership, and hands-on execution — built for the complexity of modern biotech development and CDMO partnerships.
Design and build phase-appropriate, scalable QMS structures aligned with your development stage, operational reality, and capital efficiency. The right system — not the biggest or smallest.
Biotech · CDMOQualified Person services and QP strategy to strengthen asset credibility, clarify IMP governance, and ensure due diligence readiness for in- and out-licensing transactions.
Biotech · CDMORisk-based CDMO and supplier partner selection frameworks that strengthen oversight, clarify accountability, and protect execution value throughout development and manufacturing.
CDMO · GovernanceEvaluation and optimization of QMS structures and process performance for inspection readiness. Audit programs, findings remediation, and CAPA governance — hands-on where required.
GxP · InspectionDesign, establish, and strengthen GMP QC laboratories — from testing strategy, facility layout, workflows, equipment, digital systems, method transfer, validation, and staffing through operational launch. We also optimize capacity, investigation performance, and data integrity, and lead focused remediation where laboratories face backlog, compliance, or inspection risk.
QC · GMP · Laboratory OperationsQuality and CMC due diligence for in- and out-licensing and M&A transactions. Structured assessment of QMS maturity, manufacturing risk, and regulatory documentation to protect deal value.
BD · Licensing · M&AWe work with organizations where the stakes are high and quality excellence is non-negotiable — from advisory to hands-on execution.
Whether entering Phase I or scaling toward later-stage development, we help build quality infrastructure that matches ambition without overbuilding for the current stage.
We help CDMOs sharpen their quality positioning, strengthen governance structures, and demonstrate the operational robustness that clients and regulators demand.